CWC
IMGN

Carolinas Wealth Consulting’s Immunogen Inc IMGN Stock Holding History

Carolinas Wealth Consulting’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-213
Closed -$1K – 966
2022
Q1 		$1K Hold
213
– – ﹤0.01% 904
2021
Q4 		$2K Hold
213
– – ﹤0.01% 856
2021
Q3 		$1K Hold
213
– – ﹤0.01% 928
2021
Q2 		$1K Hold
213
– – ﹤0.01% 935
2021
Q1 		$2K Sell
213
-119
-36% -$972 ﹤0.01% 841
2020
Q4 		$2K Buy
332
+213
+179% +$1.24K ﹤0.01% 768
2020
Q3 		$0 Buy
+119
New +$480 ﹤0.01% 1014

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Carolinas Wealth Consulting's IMGN Position: Q2 2022 in Review

Carolinas Wealth Consulting sold out of Immunogen Inc (IMGN) in Q2 2022, closing a stake of 213 shares — an estimated $1K sold.

Carolinas Wealth Consulting first reported a position in IMGN in Q3 2020 and held it in 7 quarters. The position peaked at $2K in Q4 2021. 216 funds tracked by Wall St. Rank hold IMGN as of Q2 2022.

  • Carolinas Wealth Consulting reported no remaining Immunogen Inc position as of Q2 2022 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 213 Immunogen Inc shares in Q2 2022, an estimated $1K.
  • Carolinas Wealth Consulting first reported a position in Immunogen Inc in Q3 2020 and held it in 7 quarters.
  • Carolinas Wealth Consulting's Immunogen Inc position peaked at $2K in Q4 2021.
  • 216 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2022.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2022, filed 16 Aug 2022.